重症监护病房常见菌感染及耐药性分析  

Analysis of Common Bacteria Infections and Their Antimicrobial Resistance in ICU

作　　者：杨伟华[1] 郭志勤[1] 谢光雄[1] 杨文[1] 

机构地区：[1]东莞市人民医院,广东东莞523018

出　　处：《抗感染药学》2008年第3期167-169,共3页Anti-infection Pharmacy

摘　　要：目的:研究重症监护病房(ICU)病原菌感染及耐药性,为合理使用抗生素提供依据。方法:对2006年1月—2007年12月送检的ICU患者各种标本分离的菌株进行统计分析。结果:所有的病原菌中G^-杆菌占57.50%(其中:鲍曼不动杆菌占17.70%,铜绿假单胞菌占15.10%)。药敏试验显示:各病原菌耐药率较高(其中:G^+菌占31.10%,金黄色葡萄球菌占11.30%,表皮葡萄球菌占13.60%,真菌占11.40%)。结论:加强ICU病房感染管理和对细菌耐药性的监测,合理使用抗生素是减少细菌耐药性,减少耐药菌产生的关键。Objective： To study research intensive care unit （ICU） infection and drug resistance of pathogenic bacteria and to provide a basis for the rational use of antibiotics. Methods： Statistically analyze the strains of specimens from patients in ICU during January, 2006 to December, 2007. Results： G bacilli accounted for 57.50% in all the pathogens, of which acinetobacter baumannii accounted for 17.70%, and pseudomonas aeruginosa accounted for 15.10%. Sensitivity test showed that the level of resistance was a little higher.Of which the G^＋ bacteria accounted for 31.10%, staphylococcus aureus accounted for 11.30%, staphylococcus epidermidis accounting for 13.60%, and the fungi was 11.40%. Conclusion： The key to reduce bacterial resistance and drug-resistant is the strengthening the management of infection in ICU the monitoring bacterial resistance, and the rational use of antibiotics.

关 键 词：重症监护病房 病原菌 耐药性 

分 类 号：R915[医药卫生—微生物与生化药学]